Consult this session to learn more about how to efficiently manage LAA closure for stroke prevention, thanks to a compelling LIVE demonstration from Institut Cardiovasculaire Paris Sud, France, during EuroPCR 2019. Discover the case of a 81 years-old female with intracranial hemmorrhage  and multiple cerebral cavernomatosis; watch the treatment...

Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.

Nicola Ryan provides her take on the WARRIOR trial which was presented by Eileen Handberg at ACC.25 in Chicago.

The manuscript for this trial has not been published and all assumptions are based upon the presentation.